Glucocorticoid Toxicity Index
GTI Magazine

To read the complete article please Click here

The one weighted outcome measure of steroid toxicity is now an FDA 21 CFR Part 11 Enabled app

Fast, accurate, and easy to implement. The standard for measuring steroid toxicity in clinical trials.

Glucocorticoids are under-studied, overused, and toxic.

More than 2/3
of trial patients receive steroids without routine monitoring of toxicity.
10 million
new steroid prescriptions written per year in the US.
increase in long-term oral glucocorticoid prescriptions over the past 20 years.
Finally, an accurate score of steroid treatment safety for CROs and investigators.

The era of finding the best steroid-sparing therapies has begun. In support of this goal, the GTI equips clinical investigators to study and score steroid toxicity over the course of clinical trials.

Why GTI 2.0?
The GTI App provides a 360° view of patients' results.
Using data recorded by both trial coordinators and clinician investigators, the GTI App gives a more complete picture of each patient.
The GTI Platform
For clinical investigators, by clinical investigators.

The Glucocorticoid Toxicity Index (GTI) was developed through data-driven approaches, expert consensus, and multi-criteria decision analysis. All 20 physician experts in the development group are clinical investigators and international authorities in subspecialties including rheumatology, pulmonary medicine, nephrology, neurology, psychiatry, dermatology, maternal-fetal medicine, and infectious disease.